Jocasta Neuroscience
PrivateLast Round
Series A
Aug 12, 2025
Total Funding Raised
$35M
Company Overview
Jocasta Neuroscience, Inc. is a pre-clinical stage biotechnology company focused on longevity and cognitive health. The company is developing JN-0413, a proprietary formulation of the a-Klotho protein, as a potential treatment for cognitive decline associated with neurodegenerative diseases such as Alzheimer's. The company's research is built on foundational data demonstrating the role of a-Klotho in health and its potential for cognitive enhancement, which has been observed in multiple species. Jocasta Neuroscience raised $35 million in a Series A financing round in August 2025 to advance its lead compound through Phase 1 clinical trials, with an Investigational New Drug (IND) submission planned for late 2026. The company was founded in 2021 and is backed by neuroscientists and longevity experts.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jocasta Neuroscience Comps
Public and private peers based on sector, stage, and business model.
Jocasta Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2025 |
Jocasta Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SC8 Investments | Series A |
| Moore Strategic Ventures | Series A |
| Glentura | Series A |
| Moore Capital Management | Series A |
| True Ventures | Series A |
Jocasta Neuroscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jocasta Neuroscience's valuation, stock price, and market status.
